(Q34659646)

English

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

based on heuristic

inferred from title

sexual dysfunction

1 reference

based on heuristic

inferred from title

Mohammad Reza Safarinejad

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Mohammad R Safarinejad

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

15 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

370-378

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tadalafil reversal of sexual dysfunction caused by serotonin enhancing medications in women

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

SSRI-associated sexual dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Bupropion-sustained release as a treatment for SSRI-induced sexual side effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Sexual dysfunction in the United States: prevalence and predictors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Use of bupropion in combination with serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109351966

21 January 2018

Identifiers

10.1177/0269881109351966

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20080928%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34659646&oldid=1507506739"